Vimarsana
Biggest News Aggregation in the World

Specialty Generics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Specialty Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Specialty Generics Today - Breaking & Trending Today

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients - Vimarsana News

Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients

Published: March 11, 2024

/PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the publication of findings from a retrospective chart review of...

Source: prnewswire.com
Related Topics:
United StatesSan FranciscoNew YorkDerek BelzMary McgowanData SciencesGreen Room CommunicationsMallinckrodt PharmaceuticalsAmerican College Of Chest PhysiciansAmerican Thoracic Society Annual International ConferenceFoundation For Sarcoidosis ResearchAmerican Medical Association Physician MasterfileDrug AdministrationActhar GelAfrican AmericansAfrican AmericanClinical RiskThoracic Society Annual International ConferenceTherapeutic AdvancesRespiratory DiseaseImportant Safety InformationGeorge WanVice PresidentEvidence GenerationChief Executive Officer
Mallinckrodt Announces Board of Directors and Leadership Updates - Vimarsana News

Mallinckrodt Announces Board of Directors and Leadership Updates

Published: February 2, 2024

/PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced the appointments of Paul Bisaro,...

Source: prnewswire.com
Related Topics:
Eli LillyDaniel SpecialePaul BisaroZimmer BiometKatina DortonDavid StetsonJon ZinmanAspen PharmacarePrnewswire MallinckrodtJoele FrankAbbas HussainWilkinson Brimmer KatcherSiggi OlafssonMichael Freitag Aaron PalashWesley WheelerDerek BelzWes WheelerPharmaceuticals VaccinesMallinckrodt PharmaceuticalsCompany Specialty BrandsGlobal Manufacturing At Valeant PharmaceuticalsAmneal PharmaceuticalsTeva PharmaceuticalsMorgan StanleyBarr Pharmaceuticals
Arvinas Appoints Jared Freedberg as General Counsel - Vimarsana News

Arvinas Appoints Jared Freedberg as General Counsel

Published: January 16, 2024

Awards Mr. Freedberg an Inducement Grant in accordance with Nasdaq Listing Rule 5635NEW HAVEN, Conn., Jan. 16, 2024 -- Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of...

Source: marketscreener.com
Related Topics:
Jared FreedbergJeff BoyleKirsten OwensJohn HoustonMallinckrodt PharmaceuticalsCounsel At Intercept PharmaceuticalsBusiness DevelopmentPfizer IncImmunomedics IncExchange CommissionArvinas CommunicationsArvinas IncInducement GrantNasdaq Listing RuleArvinas ChairpersonChief Executive OfficerGeneral CounselIntercept PharmaceuticalsCorporate SecretarySpecialty GenericsVice PresidentPrivate Securities Litigation Reform ActAnnual ReportArvinas Investor
Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder - Vimarsana News

Mallinckrodt Announces FDA Clearance of the INOmax® EVOLVE™ DS Delivery System and Approval of the INOmax® (nitric oxide) Mini-Cylinder

Published: December 7, 2023

/PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the INOmax® EVOLVE™ DS delivery system has been cleared by...

Source: prnewswire.com
Related Topics:
United KingdomDerek BelzDanielj SpecialePrnewswire MallinckrodtGreen Room CommunicationsDrug AdministrationErgonomics SocietyMallinckrodt PharmaceuticalsHuman FactorsDevice WarningsImportant Safety InformationExecutive Vice PresidentChief Scientific OfficerStanley Caplan User Centered Product DesignAdam ShamesNitric OxideFull PrescribingSpecialty BrandsSpecialty GenericsAnnual ReportVice PresidentChief Financial OfficerMallinckrodt Plc
Specialty Generics Market Analysis and Future Prospects for 2030 - Vimarsana News

Specialty Generics Market Analysis and Future Prospects for 2030

Published: November 20, 2023

Specialty Generics Market Analysis and Future Prospects for 2030

Source: pr-inside.com
Related Topics:
United StatesParmeet SinghAsia PacificApotex CorpSandoz International GmbSun Pharmaceutical Industries LtdTeva Pharmaceuticals IndustriesPfizer IncEndo InternationalAkorn IncValeant PharmaceuticalsDhirtek Business ResearchSample ReportComprehensive AnalysisSpecialty GenericsSandoz International GmbhPath ForwardStrategic ImplicationsCompetitive LandscapeRetail PharmaciesSpecialty PharmaciesHospital PharmaciesRegional DynamicsNorth AmericaLatin America